Atlas Trials

Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults

Clinical trial NCT07176208 · RECRUITING

Trial details

NCT number
NCT07176208
Sponsor
Food and Drug Administration (FDA)
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cannabis, Drug EffectsDriving Performance
Start date
2025-12-29
Primary completion
2026-04-14
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.